Eli Lilly and Company /
Ventyx Biosciences, Inc.
Eli Lilly and Company agrees to buy Ventyx Biosciences, Inc.
Source for the buyer and target: Ventyx Biosciences, Inc.
For the buyer and target.
“As previously disclosed in the Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on January 7, 2026, Ventyx Biosciences, Inc. (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated January 7, 2026, with Eli Lilly and Company, an Indiana corporation (“Parent”), and Parent’s wholly owned subsidiary, RYLS Merger Corporation, a Delaware corporation (“Merger Sub”).”
Published 4 Mar 2026
Open the sourceWhat happened
Eli Lilly and Company agreed to acquire Ventyx Biosciences, Inc. for $1.2 billion, according to a filing dated March 4, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Eli Lilly and Company agrees to buy Ventyx Biosciences, Inc.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Eli Lilly and Company agrees to buy Ventyx Biosciences, Inc. Eli Lilly and Company agreed to acquire Ventyx Biosciences, Inc. for $1.2 billion, according to a filing dated March 4, 2026”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly